StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
AstraZeneca PLC
LSE:AZN.L
Sector
Location
Market Cap
USD 216.30 B
Share Price
USD 139.36
Avg Daily Volume
2,582,257
Change (1 day)
-1.60%
Change (1 year)
-8.99%
Change (YTD)
6.41%
AstraZeneca PLC Free Cash Flow for the year ending December 31, 2024: USD 7.28 B
AstraZeneca PLC Free Cash Flow is USD 7.28 B for the year ending December 31, 2024, a 10.78% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
-
AstraZeneca PLC Free Cash Flow for the year ending December 31, 2023 was USD 6.57 B, a -9.26% change year over year.
-
AstraZeneca PLC Free Cash Flow for the year ending December 31, 2022 was USD 7.24 B, a 92.32% change year over year.
-
AstraZeneca PLC Free Cash Flow for the year ending December 31, 2021 was USD 3.76 B, a 71.59% change year over year.
-
AstraZeneca PLC Free Cash Flow for the year ending December 31, 2020 was USD 2.19 B, a 330.84% change year over year.
Competitors
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 68.84
NOVO-B.CO
-0.79
-1.13%
Roche Holding AG
USD 344.49
RO.SW
-3.19
-0.92%
Novartis AG
USD 121.35
NOVN.SW
-2.55
-2.06%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
Merck & Co., Inc.
USD 80.96
MRK
-1.43
-1.74%
Amgen Inc.
USD 298.52
AMGN
+1.67
0.56%
Pfizer Inc.
USD 25.39
PFE
+0.07
0.30%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 96.95
SAN.PA
-1.69
-1.71%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 48.89
4519.T
+0.35
0.72%
GSK plc
USD 19.04
GSK.L
-0.17
-0.91%
CSL Limited
USD 158.35
CSL.AX
+0.51
0.32%
Regeneron Pharmaceuticals, Inc.
USD 547.36
REGN
-0.38
-0.07%
MERCK Kommanditgesellschaft auf Aktien
USD 130.20
MRK.DE
-2.77
-2.08%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.47
600276.SS
+0.15
2.03%
Takeda Pharmaceutical Company Limited
USD 30.58
4502.T
+0.07
0.24%
Alnylam Pharmaceuticals, Inc.
USD 331.91
ALNY
+2.14
0.65%
Key Data
| Date | Free Cash Flow | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities |
|---|
Competitors
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 68.84
NOVO-B.CO
-0.79
-1.13%
Roche Holding AG
USD 344.49
RO.SW
-3.19
-0.92%
Novartis AG
USD 121.35
NOVN.SW
-2.55
-2.06%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
Merck & Co., Inc.
USD 80.96
MRK
-1.43
-1.74%
Amgen Inc.
USD 298.52
AMGN
+1.67
0.56%
Pfizer Inc.
USD 25.39
PFE
+0.07
0.30%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 96.95
SAN.PA
-1.69
-1.71%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 48.89
4519.T
+0.35
0.72%
GSK plc
USD 19.04
GSK.L
-0.17
-0.91%
CSL Limited
USD 158.35
CSL.AX
+0.51
0.32%
Regeneron Pharmaceuticals, Inc.
USD 547.36
REGN
-0.38
-0.07%
MERCK Kommanditgesellschaft auf Aktien
USD 130.20
MRK.DE
-2.77
-2.08%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.47
600276.SS
+0.15
2.03%
Takeda Pharmaceutical Company Limited
USD 30.58
4502.T
+0.07
0.24%
Alnylam Pharmaceuticals, Inc.
USD 331.91
ALNY
+2.14
0.65%